跳至主要内容
临床试验/NCT01946841
NCT01946841撤回2 期

Effets de la Nutrition entérale spécifique RealDiet®Renal (NES) Chez Des Patients Insuffisants rénaux hémodialysés dénutris : efficacité, tolérance, qualité de Vie.

Lactalis2 个研究点 分布在 1 个国家开始时间: 2013年8月1日最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
发起方
Lactalis
试验地点
2
主要终点
Evolution of serum prealbumin and albumin.

研究概览

简要总结

The objective of this unblinded study is to assess the nutritional effects of a 12 weeks administration of the specific enteral nutrition (SEN) RealDiet®Renal pockets, as well as the impact on the patients' quality of life.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic kidney disease patient on hemodialysis for at least 3 months, with a minimum of three hemodialysis sessions of 4 hours per week
  • Patients aged 18 years
  • Written, free and informed consent given by the Patient
  • Patient insured under the social security system or equivalent
  • Patients who did not receive enteral nutrition during the 3 months preceding inclusion ; taking an oral nutritional supplement, or per-dialytic parenteral nutrition or total parenteral nutrition is not a criterion of non-inclusion
  • Patient in a state of malnutrition
  • defined by the presence of at least 3 out of 5 of the following criteria :
  • weight loss greater than 10% observed in the last six months
  • serum albumin <35 g / l
  • serum Prealbumin <300 mg / l
  • NPNA <1 g / kg / day for 2 consecutive months
  • presenting
  • food intake <20 kcal / kg / day or
  • failure of other nutritional care methods, namely, oral nutritional supplements and / or peridialytic parenteral nutrition, or total parenteral nutrition
  • lack of compliance after one month, to the nutritional care methods mentioned above. • Patients for whom the decision to prescribe enteral feeding was previously taken

排除标准

  • Patients with a history of intolerance to enteral feeding
  • Index Kt/Veq (balanced) < or = 1.2 or index Kt/Vsp (single pool) < or = 1.4 according to the method used
  • Patients with a disease compromising the short-term (4-6 months) prognosis (cancer or other disease in the terminal phase)
  • Pregnant Patient
  • Patient with a known allergy to at least one of the following : milk protein, soy, fish
  • Patient whose digestive tract is not functional or patient in shock
  • Patient protected under guardianship
  • Patient in exclusion period after participation in another clinical trial.

结局指标

主要结局

Evolution of serum prealbumin and albumin.

时间窗: 6 months

Evaluate during 3 months specific enteral nutrition (SEN) treatment, and 3 months after treatment interruption, the effects of the study product on the evolution of serum prealbumin and albumin.

次要结局

  • Evolution of nutritional status during 3 months of enteral nutrition, and during 3 months after end of treatment.(6 months)
  • Evolution of quality of life during 3 months of enteral nutrition, and during 3 months after end of treatment.(6 months)
  • Evolution of tolerance of study product during 3 months of enteral nutrition.(3 mois)

研究者

发起方
Lactalis
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验